ALLO

Allogene TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

ALLO vs peer average

76/100

ALLO vs. peer average (A vs. C)

Grade spread

A 2 · B 1 · C 4 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

DSGN is the first available peer comparator.

Similarly sized clinical-stage biotech peer; useful comparator for binary data/readout risk and low-liquidity rerating dynamics.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerDSGNDesign Therapeutics

ALLO

Allogene Therapeutics

DSGN

Design Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs DSGN

ALLO / DSGN

Grade Position

Above peers

ALLO vs. peer average (A vs. C)

76/100

Momentum

ALLO

Value

ALLO

Sentiment

DSGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ALLO

DSGN

60/100

BBOT

20/100

REPL

Replimune Group Inc Common

60/100

AURA

Aura Biosciences Inc Common

100/100

Even

PHAT

Phathom Pharmaceuticals Inc Common

60/100

DSGN is the first peer returned for this comparison set.